Krambeck Amy E, LeRoy Andrew J, Patterson David E, Gettman Matthew T
Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55906, USA.
J Urol. 2008 Jun;179(6):2233-7. doi: 10.1016/j.juro.2008.01.115. Epub 2008 Apr 18.
Percutaneous nephrolithotomy is successful at achieving stone-free status but long-term safety data are lacking. We report our long-term experience with percutaneous nephrolithotomy and compare these results with other treatment modalities.
We identified 87 patients treated with percutaneous nephrolithotomy from 1983 to 1984 who continue to receive care at our institution. Retrospective chart review was performed. Long-term results were compared to those of a group of 288 patients with stones treated nonsurgically (controls) and a group of 288 patients treated with shock wave lithotripsy followed for 19 years.
Average followup was 19.2 years (range 12.7 to 23.0). After percutaneous nephrolithotomy new onset renal insufficiency was noted in 9 patients (10.6%), hypertension in 29 (34.1%), diabetes mellitus in 20 (23.5%) and ureteropelvic junction obstruction in 3 (3.5%). Stone recurrence occurred in 32 patients (36.8%). Recurrent stone events were associated with residual fragments after percutaneous nephrolithotomy (p = 0.049). Compared to shock wave lithotripsy there were no significant differences in the development of renal insufficiency, hypertension or diabetes mellitus. Stone recurrence was more common following shock wave lithotripsy (53.5%) compared to percutaneous nephrolithotomy (p = 0.033). Compared to controls there were no significant differences in the development of renal insufficiency or hypertension. On univariate analysis percutaneous nephrolithotomy was associated with the development of diabetes mellitus (p <0.001) but this association did not persist in multivariate analysis.
At 19 years of followup stone recurrences were less frequent following percutaneous nephrolithotomy compared to shock wave lithotripsy. Recurrent stone events were associated with residual fragments after percutaneous nephrolithotomy. Percutaneous nephrolithotomy was not associated with the development of adverse medical conditions compared to shock wave lithotripsy or conservatively managed stone cases.
经皮肾镜取石术在实现无石状态方面是成功的,但缺乏长期安全性数据。我们报告我们经皮肾镜取石术的长期经验,并将这些结果与其他治疗方式进行比较。
我们确定了1983年至1984年接受经皮肾镜取石术且继续在我们机构接受治疗的87例患者。进行了回顾性病历审查。将长期结果与一组288例非手术治疗结石的患者(对照组)以及一组接受冲击波碎石术并随访19年的288例患者的结果进行比较。
平均随访时间为19.2年(范围12.7至23.0年)。经皮肾镜取石术后,9例患者(10.6%)出现新发肾功能不全,29例(34.1%)出现高血压,20例(23.5%)出现糖尿病,3例(3.5%)出现输尿管肾盂连接处梗阻。32例患者(36.8%)出现结石复发。经皮肾镜取石术后复发结石事件与残余碎片相关(p = 0.049)。与冲击波碎石术相比,肾功能不全、高血压或糖尿病的发生无显著差异。与经皮肾镜取石术相比,冲击波碎石术后结石复发更常见(53.5%)(p = 0.033)。与对照组相比,肾功能不全或高血压的发生无显著差异。单因素分析显示经皮肾镜取石术与糖尿病的发生相关(p <0.001),但在多因素分析中这种关联未持续存在。
随访19年时,与冲击波碎石术相比,经皮肾镜取石术后结石复发频率较低。经皮肾镜取石术后复发结石事件与残余碎片相关。与冲击波碎石术或保守治疗的结石病例相比,经皮肾镜取石术与不良医疗状况的发生无关。